Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMBALAL SARABHAI Gains 9%; BSE HEALTHCARE Index Up 0.8%
Wed, 6 Nov 10:7

AMBALAL SARABHAI Gains 9%; BSE HEALTHCARE Index Up 0.8%Image source: Kameleon007 /www.istockphoto.com

AMBALAL SARABHAI share price has zoomed 9% and is presently trading at Rs 61.6.

Meanwhile, the BSE HEALTHCARE index is at 44,284.8 (up 0.8%).

Among the top gainers in the BSE HEALTHCARE index today are Procter & Gamble Health (up 3.4%) and Dr. Reddys (up 2.1%).

Jubilant Pharmova (down 0.7%) and SUVEN PHARMACEUTICALS (down 0.6%) are among the top losers today.

Over the last one year, AMBALAL SARABHAI has moved up from Rs 36.5 to Rs 61.6, registering a gain of Rs 25.1 (up 68.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,089.2 to 44,284.8, registering a gain of 57.7% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 207.3%), SUVEN PHARMACEUTICALS (up 132.2%) and Glenmark Pharma (up 129.3%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 79,982.6 (up 0.6%).

The top gainers among the BSE Sensex today are HCl Tech. (up 3.1%) and Infosys (up 2.9%). The most traded stocks in the BSE Sensex are ITC and Infosys.

In the meantime, NSE Nifty is at 24,401.2 (up 0.8%). Trent and HCl Tech. are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,958.7 to 79,982.6, registering a gain of 15,023.9 points (up 23.1%).

AMBALAL SARABHAI Financial Update...

AMBALAL SARABHAI net profit grew 118.2% YoY to Rs 7 million for the quarter ended June 2024, compared to a loss of Rs 39 million a year ago. Net sales rose 12.7% to Rs 407 million during the period as against Rs 361 million in April-June 2023.

For the year ended March 2024, AMBALAL SARABHAI reported 50.4% decrease in net profit to Rs 57 million compared to net profit of Rs 114 million during FY23. Revenue of the company grew 1.9% to Rs 1,736 million during FY24.

The current Price to earnings ratio of AMBALAL SARABHAI, based on rolling 12 month earnings, stands at 36.3.


Equitymaster requests your view! Post a comment on "AMBALAL SARABHAI Gains 9%; BSE HEALTHCARE Index Up 0.8%". Click here!